According to this study, the global Lung-on-a-chip market size will reach US$ million by 2030.
³¢³Ü²Ô²µÌý´Ç²ÔÌý²¹Ìý³¦³ó¾±±è.Ìý°Õ³ó±ðÌý»å±ð±¹¾±³¦±ðÌý¾±²õÌý³¾²¹»å±ðÌý³Ü²õ¾±²Ô²µÌý³ó³Ü³¾²¹²ÔÌý±ô³Ü²Ô²µÌý²¹²Ô»åÌý²ú±ô´Ç´Ç»åÌý±¹±ð²õ²õ±ð±ôÌý³¦±ð±ô±ô²õÌý²¹²Ô»åÌý¾±³ÙÌý³¦²¹²ÔÌý±è°ù±ð»å¾±³¦³ÙÌý²¹²ú²õ´Ç°ù±è³Ù¾±´Ç²ÔÌý´Ç´ÚÌý²¹¾±°ù²ú´Ç°ù²Ô±ðÌý²Ô²¹²Ô´Ç±è²¹°ù³Ù¾±³¦±ô±ð²õÌý²¹²Ô»åÌý³¾¾±³¾¾±³¦Ìý³Ù³ó±ðÌý¾±²Ô´Ú±ô²¹³¾³¾²¹³Ù´Ç°ù²âÌý°ù±ð²õ±è´Ç²Ô²õ±ðÌý³Ù°ù¾±²µ²µ±ð°ù±ð»åÌý²ú²âÌý³¾¾±³¦°ù´Ç²ú¾±²¹±ôÌý±è²¹³Ù³ó´Ç²µ±ð²Ô²õ.Ìý±õ³ÙÌý³¦²¹²ÔÌý²ú±ðÌý³Ü²õ±ð»åÌý³Ù´ÇÌý³Ù±ð²õ³ÙÌý³Ù³ó±ðÌý±ð´Ú´Ú±ð³¦³Ù²õÌý´Ç´ÚÌý±ð²Ô±¹¾±°ù´Ç²Ô³¾±ð²Ô³Ù²¹±ôÌý³Ù´Ç³æ¾±²Ô²õ,Ìý²¹²ú²õ´Ç°ù±è³Ù¾±´Ç²ÔÌý´Ç´ÚÌý²¹±ð°ù´Ç²õ´Ç±ô¾±³ú±ð»åÌý³Ù³ó±ð°ù²¹±è±ð³Ü³Ù¾±³¦²õ,Ìý²¹²Ô»åÌý³Ù³ó±ðÌý²õ²¹´Ú±ð³Ù²âÌý²¹²Ô»åÌý±ð´Ú´Ú¾±³¦²¹³¦²âÌý´Ç´ÚÌý²Ô±ð·ÉÌý»å°ù³Ü²µ²õ.
Following a strong growth of 26.2 percent in the year 2021, WSTS revised it down to a single digit growth for the worldwide semiconductor market in 2022 with a total size of US$580 billion, up 4.4 percent. WSTS lowered growth estimation as inflation rises and end markets seeing weaker demand, especially those exposed to consumer spending. While some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.8 percent, Sensors with 16.3 percent, and Logic with 14.5 percent growth. Memory declined with 12.6 percent year over year. In 2022, all geographical regions showed double-digit growth except Asia Pacific. The largest region, Asia Pacific, declined 2.0 percent. Sales in the Americas were US$142.1 billion, up 17.0% year-on-year, sales in Europe were US$53.8 billion, up 12.6% year-on-year, and sales in Japan were US$48.1 billion, up 10.0% year-on-year. However, sales in the largest Asia-Pacific region were US$336.2 billion, down 2.0% year-on-year.
This report presents a comprehensive overview, market shares, and growth opportunities of Lung-on-a-chip market by product type, application, key players and key regions and countries.
Segmentation by product type:
Pulmonary Inflammation
Pulmonary Infection
Segmentation by Application:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Â鶹Դ´ Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Â鶹Դ´ Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Â鶹Դ´ Overview
2.1.1 Global Lung-on-a-chip Â鶹Դ´ Size 2024-2030
2.1.2 Lung-on-a-chip Â鶹Դ´ Size CAGR by Region
2.2 Lung-on-a-chip Segment by Type
2.2.1 Pulmonary Inflammation
2.2.2 Pulmonary Infection
2.3 Lung-on-a-chip Â鶹Դ´ Size by Type
2.3.1 Global Lung-on-a-chip Â鶹Դ´ Size Â鶹Դ´ Share by Type (2024-2030)
2.3.2 Global Lung-on-a-chip Â鶹Դ´ Size Growth Rate by Type (2024-2030)
2.4 Lung-on-a-chip Segment by Application
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Academic & Research Institutes
2.4.3 Other End Users
2.5 Lung-on-a-chip Â鶹Դ´ Size by Application
2.5.1 Global Lung-on-a-chip Â鶹Դ´ Size Â鶹Դ´ Share by Application (2024-2030)
2.5.2 Global Lung-on-a-chip Â鶹Դ´ Size Growth Rate by Application (2024-2030)
3 Lung-on-a-chip Key Players
3.1 Date of Key Players Enter into Lung-on-a-chip
3.2 Key Players Lung-on-a-chip Product Offered
3.3 Key Players Lung-on-a-chip Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Lung-on-a-chip Valuation & Â鶹Դ´ Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Â鶹Դ´ Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Lung-on-a-chip by Regions
4.1 Lung-on-a-chip Â鶹Դ´ Size by Regions (2024-2030)
4.2 United States Lung-on-a-chip Â鶹Դ´ Size Growth (2024-2030)
4.3 China Lung-on-a-chip Â鶹Դ´ Size Growth (2024-2030)
4.4 Europe Lung-on-a-chip Â鶹Դ´ Size Growth (2024-2030)
4.5 Rest of World Lung-on-a-chip Â鶹Դ´ Size Growth (2024-2030)
5 United States
5.1 United States Lung-on-a-chip Â鶹Դ´ Size by Type (2024-2030)
5.2 United States Lung-on-a-chip Â鶹Դ´ Size by Application (2024-2030)
6 Europe
6.1 Europe Lung-on-a-chip Â鶹Դ´ Size by Type (2024-2030)
6.2 Europe Lung-on-a-chip Â鶹Դ´ Size by Application (2024-2030)
7 China
7.1 China Lung-on-a-chip Â鶹Դ´ Size by Type (2024-2030)
7.2 China Lung-on-a-chip Â鶹Դ´ Size by Application (2024-2030)
8 Rest of World
8.1 Rest of World Lung-on-a-chip Â鶹Դ´ Size by Type (2024-2030)
8.2 Rest of World Lung-on-a-chip Â鶹Դ´ Size by Application (2024-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Â鶹Դ´ Drivers, Challenges and Trends
9.1 Â鶹Դ´ Drivers & Growth Opportunities
9.2 Â鶹Դ´ Challenges & Risks
9.3 Industry Trends
10 Key Investors in Lung-on-a-chip
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Â鶹Դ´ Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Â鶹Դ´ Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Â鶹Դ´ Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Lung-on-a-chip Product Offered
11.1.3 Emulate Lung-on-a-chip Â鶹Դ´ Size (2024 VS 2030)
11.1.4 Emulate Main Business Overview
11.1.5 Emulate News
11.2 Tissuse
11.2.1 Tissuse Company Details
11.2.2 Tissuse Lung-on-a-chip Product Offered
11.2.3 Tissuse Lung-on-a-chip Â鶹Դ´ Size (2024 VS 2030)
11.2.4 Tissuse Main Business Overview
11.2.5 Tissuse News
11.3 Hesperos
11.3.1 Hesperos Company Details
11.3.2 Hesperos Lung-on-a-chip Product Offered
11.3.3 Hesperos Lung-on-a-chip Â鶹Դ´ Size (2024 VS 2030)
11.3.4 Hesperos Main Business Overview
11.3.5 Hesperos News
11.4 CN Bio Innovations
11.4.1 CN Bio Innovations Company Details
11.4.2 CN Bio Innovations Lung-on-a-chip Product Offered
11.4.3 CN Bio Innovations Lung-on-a-chip Â鶹Դ´ Size (2024 VS 2030)
11.4.4 CN Bio Innovations Main Business Overview
11.4.5 CN Bio Innovations News
11.5 Draper Laboratory
11.5.1 Draper Laboratory Company Details
11.5.2 Draper Laboratory Lung-on-a-chip Product Offered
11.5.3 Draper Laboratory Lung-on-a-chip Â鶹Դ´ Size (2024 VS 2030)
11.5.4 Draper Laboratory Main Business Overview
11.5.5 Draper Laboratory News
11.6 Mimetas
11.6.1 Mimetas Company Details
11.6.2 Mimetas Lung-on-a-chip Product Offered
11.6.3 Mimetas Lung-on-a-chip Â鶹Դ´ Size (2024 VS 2030)
11.6.4 Mimetas Main Business Overview
11.6.5 Mimetas News
11.7 Nortis
11.7.1 Nortis Company Details
11.7.2 Nortis Lung-on-a-chip Product Offered
11.7.3 Nortis Lung-on-a-chip Â鶹Դ´ Size (2024 VS 2030)
11.7.4 Nortis Main Business Overview
11.7.5 Nortis News
11.8 Kirkstall
11.8.1 Kirkstall Company Details
11.8.2 Kirkstall Lung-on-a-chip Product Offered
11.8.3 Kirkstall Lung-on-a-chip Â鶹Դ´ Size (2024 VS 2030)
11.8.4 Kirkstall Main Business Overview
11.8.5 Kirkstall News
11.9 Cherry Biotech SAS
11.9.1 Cherry Biotech SAS Company Details
11.9.2 Cherry Biotech SAS Lung-on-a-chip Product Offered
11.9.3 Cherry Biotech SAS Lung-on-a-chip Â鶹Դ´ Size (2024 VS 2030)
11.9.4 Cherry Biotech SAS Main Business Overview
11.9.5 Cherry Biotech SAS News
11.10 Else Else Kooi Laboratory
11.10.1 Else Else Kooi Laboratory Company Details
11.10.2 Else Else Kooi Laboratory Lung-on-a-chip Product Offered
11.10.3 Else Else Kooi Laboratory Lung-on-a-chip Â鶹Դ´ Size (2024 VS 2030)
11.10.4 Else Else Kooi Laboratory Main Business Overview
11.10.5 Else Else Kooi Laboratory News
11.11 Micronit Microtechnologies B.V.
12 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.
